Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Community
/
Ideas
/
✳️ DYDX Confirmed Support Leads To 130%+ Potential
DYDX / Bitcoin
Long
✳️ DYDX Confirmed Support Leads To 130%+ Potential
By AlanSantana
Follow
Follow
Mar 18, 2023
1
0
Mar 18, 2023
Many signals here confirm support and support a higher high as the next target for DYDXBTC... Let's dive in.
First, we have a higher low in January 2023 vs September 2022.
Again in January we have the first break of MA200 (black line) as resistance.
Earlier this month MA200 gets tested as support, three times and it holds.
As it was tested for the last time yesterday, we see an uptick in buying pressure/increasing volume right after.
The MACD and RSI both curving upwards and this is all pointing to higher prices.
✔️
These signals are pointing to 0.00023900 as the next target or 130%+ potential from the current price.
This is a decentralized exchange (DEX) and it is set for growth.
Invalidation happens after several sessions closing below MA200.
Namaste.
altcoins
Chart Patterns
crypto
Cryptocurrency
DEX
dydx
DYDXBTC
Technical Indicators
Trend Analysis
AlanSantana
Follow
🔥 PREMIUM Trade-Numbers
lamatrades.com
(Since 2017)
🏆 Results:
t.me/alansantana1111/5935
🥇XRP +1950 🥇ADA +2216% 🥇AVA +536% 🥇AAVE +417%
t.me/alansantanatrades/971
🔝 Cryptocurrency Technical Analysis
followalan.com
Also on:
Related publications
✴️ Buy When Others Are Fearful... Dogecoin
by AlanSantana
✴️ Retraces & Corrections Are Opportunities To Buy | Solana
by AlanSantana
📈 Crypto Set Up For An Epic Week/Weekend
by AlanSantana
🅱️ Uranus, Will Bitcoin Hit $28,500 or $31,000 Next?
by AlanSantana
✴️ Fetch.AI Next Target Mapped ($0.8340) | Already 1,050%+
by AlanSantana
✴️ Fantom Has So Much More To Give (260% This Wave)
by AlanSantana
✴️ Cardano's Full Potential Revealed (240% to 345%)
by AlanSantana
✴️ Ripple To Win The SEC Lawsuit | XRP To Grow!
by AlanSantana
🅱️ Major Development, 1st Buy Signal Since July 2021 | Bitcoin
by AlanSantana
📈 Tether Dominance Long-Term Bearish Trend Confirmed
by AlanSantana
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.